SMi Group Announce Social Media in the Pharmaceutical Industry: Evolving a Pharma Communications Strategy for the 21st Century Conference, 6th & 7th July 2011

LONDON, May 18, 2011 /PRNewswire/ -- For more information visit

http://www.smi-online.co.uk/2011socialmedia32.asp

Building on the tremendous success of SMi's "sell-out" inaugural Social Media in the Pharmaceutical Industry conference. SMi Group is delighted to announce their Social Media in the Pharmaceutical Industry: Evolving a Pharmaceutical Communications Strategy for the 21st Century. This follow-up event is focused on keeping our audience up-to-date with developments in the ever-changing social media sphere. The conference is the premier event of its kind in Europe and the only event to focus exclusively on how social media can be used within the pharmaceutical industry and healthcare to foster patient-doctor interaction, knowledge of new treatments and also a greater understanding of various healthcare issues.

Social media is an area of communications in a state of continual evolution and flux and 2011 looks set to be a year of immense significance for the future of its application to the pharmaceutical and healthcare industry. With the long-awaited FDA guidance on social media finally expected to be released during the first quarter of 2011, the early implications of the recommendations and what they mean to those engaged in social media activities will become apparent over the course of the year.

Key topics to be addressed include:

- Social media marketing: ways to use and integrate social media platforms into your marketing strategy, ensuring an attractive ROI

- Social media monitoring: methods to measure your impact in the social media sphere, and effective ROI determination

- Social networking software and platforms: case studies illustrating different uses for various social media sites and platforms

- Corporate communications: successfully developing a social media element to your corporate communications strategy

- Interacting with patient groups: understanding the importance of interacting with online patient groups, and developing a conversational interaction

This high level conference programme will be delivered by some of the industry's senior professionals including:

Tim Lloyd, Deputy Head of Publishing & eCommunications, Department of Health, UK

Marc Monseau, Director, Corporate Communications and Social Media, Johnson & Johnson

Andrew Widger, Director, Media Relations, EMEA, Pfizer

Alex Butler, EMEA Marketing Communications Manager, Johnson & Johnson Pharmaceuticals

John Vieira, Senior Director, Marketing Operations & Strategic Services, Daiichi Sankyo

Cressida Robson, Director, European Communications, Eisai

For further information visit: http://www.smi-online.co.uk/2011socialmedia32.asp, or alternatively contact: Mohammad Saffaf on Tel: +44-(0)20-7827-6022 or Email: msaffaf@smi-online.co.uk